A monthly injection to treat opioid dependence, approved in October 2010 by the U.S. Food and Drug Administration (FDA), has gotten off to a slow start but is proving useful in helping certain patients, say doctors familiar with the drug, extended-release naltrexone (Vivitrol).
The U.S. Food and Drug Administration’s Center for Tobacco Products has announced it will review research on the impact of the use of menthol in cigarettes on the public health. The independent review will evaluate the impact of the cigarettes overall, as well as on children, African Americans, Hispanics, and other racial/ethnic minorities.
A group of U.S. senators is asking the Food and Drug Administration’s Center for Tobacco Products to regulate a new form of dissolvable tobacco products that they say poses health risks, especially for children.
The Food and Drug Administration (FDA) said on Thursday that the smoking-cessation drug Chantix (vareniclene) may be associated with a small, increased risk of certain heart problems in patients with heart disease.
The Food and Drug Administration has sent warning letters to online retailers for illegally marketing tobacco products using misleading health claims. The letter said the 11 retailers had illegally marketed tobacco products using words such as ‘light,’ ‘less toxic,’ ‘mild,’ ‘safer’ or ‘low.’
The U.S. Food and Drug Administration (FDA) announced it will regulate smokeless electronic cigarettes as tobacco products, treating them the same as traditional cigarettes. The decision comes after the FDA lost a court case in which it argued that the devices should be regulated as drug-delivery devices, which must satisfy stricter requirements.
As part of the new government plan to reduce prescription drug abuse, the U.S. Food and Drug Administration is asking manufacturers of prescription painkillers to create materials for consumers about how to safely use and dispose of opioids.